44 studies found for:    "ankyloblepharon-ectodermal defects-cleft lip palate syndrome" OR "Ectodermal Dysplasias"
Show Display Options
Rank Status Study
21 Enrolling by invitation Growth Arrest in Focal Dermal Hypoplasia
Condition: Focal Dermal Hypoplasia
Intervention:
22 Recruiting Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Condition: Basal Cell Carcinoma in Basal Cell Nevus Syndrome
Intervention: Drug: SUBA-Itraconazole
23 Recruiting International Pachyonychia Congenita Research Registry
Condition: Pachyonychia Congenita
Intervention:
24 Recruiting Erismodegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome;   Recurrent Skin Cancer
Interventions: Drug: buparlisib;   Drug: erismodegib;   Other: laboratory biomarker analysis;   Other: questionnaire administration
25 Recruiting Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: aminolevulinic acid hydrochloride;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis;   Other: questionnaire administration
26 Not yet recruiting Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
Condition: Basal Cell Nevus Syndrome
Interventions: Drug: Levulan;   Other: Red Light Photodynamic Therapy;   Other: Blue Light Photodynamic Therapy
27 Completed Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
Condition: Pachyonychia Congenita
Interventions: Drug: 1% sirolimus cream (TD201 1%);   Drug: placebo cream (vehicle control)
28 Active, not recruiting Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome
Condition: Basal Cell Nevus Syndrome
Intervention: Drug: BMS-833923
29 Completed Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas
Conditions: Basal Cell Nevus Syndrome;   Gorlin's Syndrome
Interventions: Drug: Vismodegib;   Drug: Aminolevulinic acid %20 topical solution
30 Unknown  Simvastatin Treatment of Pachyonychia Congenita
Condition: Pachyonychia Congenita
Intervention: Drug: Simvastatine
31 Completed
Has Results
Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
Conditions: Basal Cell Carcinoma;   Gorlin Syndrome;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: LDE225;   Drug: Placebo
32 Completed
Has Results
A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients
Condition: Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Interventions: Drug: Vehicle;   Drug: LDE225 0.25%;   Drug: LDE225 0.75%
33 Completed To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)
Conditions: Basal Cell Nevus Syndrome;   Gorlin Syndrome
Intervention: Drug: GDC-0449
34 Completed Natural History of Asphyxiating Thoracic Dystrophy (DTJ)
Condition: Asphyxiating Thoracic Dystrophy
Intervention: Genetic: IFT80 screening
35 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
36 Completed
Has Results
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
Condition: Skin Carcinoma
Interventions: Drug: tazarotene;   Other: placebo
37 Completed Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
Condition: Pachyonychia Congenita
Interventions: Drug: TD101;   Drug: Normal saline (placebo)
38 Recruiting Study of Selected X-linked Disorders: Goltz Syndrome
Conditions: Focal Dermal Hypoplasia (FDH);   Goltz Syndrome;   X Linked Disorders
Intervention:
39 Completed Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
Conditions: Skin Cancer;   Xeroderma Pigmentosum;   Basal Cell Nevus Syndrome
Intervention:
40 Completed
Has Results
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
Condition: Neoplastic Syndrome
Intervention: Drug: tazarotene

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-44) Show next page of results    Last Page
Indicates status has not been verified in more than two years